Luye Pharma Group Limited operates in the Medicinals and botanicals sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Luye Pharma Group Limited with three other
pharmaceutical manufacturers in Asia:
JW Holdings Corporation
of South Korea
sales of 683.72 billion Korean Won [US$637.23 million]
of which 110%
Kissei Pharmaceutical Company Limited
(71.71 billion Japanese Yen [US$665.43 million]
of which 86%
was Pharmaceutical Products), and
ChangChun High New Technology Industries
based in China
(4.04 billion Chinese Renmimbi [US$641.58 million]
of which 85%
Luye Pharma Group Limited reported sales of 777.88 million Singapore Dollars (US$590.65 million)
December of 2017.
increase of 28.4%
versus 2016, when the company's sales were 605.73 million Singapore Dollars.